{"schema_version":"secwatch.filing_event.v1","accession":"0001013762-23-006625","form_type":"8-K","ticker":"OPRX","cik":"0001448431","company_name":"OptimizeRx Corp","filed_at":"2023-10-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.104612+00:00","generated_at":"2026-06-09T10:18:52.908421+00:00","sec_items":["1.01","2.01","9.01","3.02","5.02","7.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"OptimizeRx completes $95M acquisition of Medicx Health; appoints new President and CCO","bullets":["Closed acquisition of Medicx Health for $95M in aggregate consideration (subject to adjustments).","Management investors purchased ~$10.5M of OPRX common stock at $7.223/share as part of the deal.","Steve Silvestro promoted to President, effective Oct 24; base salary increased to $400k.","Theresa Greco (former Medicx President) named Chief Commercial Officer.","Q3 2023 earnings call scheduled for Nov 6, 2023; financial results to be released prior."],"urls":{"canonical":"https://secwatch.observer/filing/0001013762-23-006625","json":"https://secwatch.observer/filing/0001013762-23-006625.json","markdown":"https://secwatch.observer/filing/0001013762-23-006625.md","text":"https://secwatch.observer/filing/0001013762-23-006625.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1448431/000101376223006625/0001013762-23-006625-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1448431/000101376223006625/ea187250-8k_optimizerx.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T10:18:52.908421+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"982b57cd3c","claim":"Stephen L. Silvestro was appointed as President at OptimizeRx Corp.","evidence_excerpt":"the Board determined to appoint Stephen L. Silvestro President of the Company effective as of the closing of the Merger.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1448431/000101376223006625/0001013762-23-006625-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President"}],"fact_type":"executive_change"},{"claim_id":"1ba28fb9137c016c75839c80e8b62edfad79f41f","claim":"OptimizeRx Corp completed an acquisition involving Healthy Offers, Inc. (d/b/a Medicx Health) for $95,000,000 (closed 2023-10-24).","evidence_excerpt":"company and a wholly-owned subsidiary of the Company (the “Merger”). The aggregate merger consideration the Company paid to the Securityholders of Medicx at the closing was $95,000,000, subject to certain customary post-acquisition purchase price adjustments. erger”). The aggregate merger consideration the Company paid to the Securityholders of Medicx at the","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1448431/000101376223006625/0001013762-23-006625-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Healthy Offers, Inc. (d/b/a Medicx Health)"},{"label":"Consideration","value":"$95,000,000"},{"label":"Closing","value":"2023-10-24"}],"fact_type":"ma_transaction"},{"claim_id":"723a1b28c5e6201f68701e78856dd9c8c1adf44f","claim":"OptimizeRx Corp entered into Subscription Agreement with Medicx Management Investors valued at 1,444,581 shares of common stock for $10.5 million (effective 2023-10-24).","evidence_excerpt":"On October 24, 2023, at the closing of the Merger, each Management Investor executed a common stock purchase agreement (the “Subscription Agreement”) to memorialize his or her purchase.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1448431/000101376223006625/0001013762-23-006625-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"Medicx Management Investors"},{"label":"Value","value":"1,444,581 shares of common stock for $10.5 million"},{"label":"Effective","value":"2023-10-24"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}